71 results
8-K
EX-99.1
NKTX
Nkarta Inc
13 Jun 24
Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of Directors
4:22pm
: the value and benefits to Nkarta of Dr. Vratsanos joining Nkarta’s Board; Nkarta’s position, plans, and strategies for the continued and future clinical
8-K
EX-1.1
NKTX
Nkarta Inc
28 Mar 24
Other Events
4:08pm
the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Securities, or (ii … the relative benefits referred to in clause (i) of this Section 7(d) but also the relative fault of the Company on the one hand and the Underwriters
8-K
EX-99.1
v2z8cilytcdxw5
25 Mar 24
Regulation FD Disclosure
6:05am
8-K
EX-99.1
bi9rv6
9 Nov 23
Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:06pm
PRE 14A
3gqkc61 qrw3mc71heq
14 Apr 23
Preliminary proxy
5:00pm
8-K
EX-1.1
7yrk 06k2
28 Apr 22
Other Events
4:20pm